Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 11-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 287 | 2,504 | 11 | 4 | N/A |
| Other current assets | 118 | 134 | 0 | 0 | 0 |
| TOTAL | $404 | $2,638 | $33 | $4 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 29 | 28 | 24 | N/A | N/A |
| Investments And Advances | 138 | 0 | 0 | 0 | 0 |
| Intangibles | 2,102 | 2,147 | 2,197 | 0 | 0 |
| Other Non-Current Assets | 0 | 138 | 138 | 0 | 0 |
| TOTAL | $2,268 | $2,313 | $2,358 | $N/A | $N/A |
| Total Assets | $2,673 | $4,951 | $2,391 | $4 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,127 | 495 | 1,047 | 10 | 0 |
| Accrued Expenses | 742 | 720 | 2,468 | 33 | N/A |
| Other current liabilities | 7,261 | N/A | 1,400 | N/A | N/A |
| TOTAL | $11,130 | $1,215 | $5,799 | $69 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 6,957 | 0 | 0 | 0 |
| TOTAL | $N/A | $6,957 | $N/A | $N/A | $N/A |
| Total Liabilities | $11,130 | $8,172 | $5,799 | $69 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,151 | 12,095 | 12,071 | 12,067 | N/A |
| Common Shares | 1 | 1 | 1 | 0 | N/A |
| Retained earnings | -43,404 | -38,355 | -33,612 | -147 | N/A |
| TOTAL | $-8,457 | $-3,222 | $-3,408 | $-65 | $N/A |
| Total Liabilities And Equity | $2,673 | $4,951 | $2,391 | $4 | $0 |